This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Leffler DA, Lamont JT. Clostridium difficile infection. The New England Journal of Medicine 2015;372:1539–1548.2587525910.1056/NEJMra1403772LefflerDALamontJTClostridium difficile infectionThe New England Journal of Medicine201537215391548Search in Google Scholar
Jandhyala SM, Talukdar R, Subramanyam C, Vuyyuru H, Sasikala M, Reddy N. Role of the normal gut microbiota. World Journal of Gastroenterology 2015, 8787–8803.26269668JandhyalaSMTalukdarRSubramanyamCVuyyuruHSasikalaMReddyNRole of the normal gut microbiotaWorld Journal of Gastroenterology20158787880310.3748/wjg.v21.i29.8787Search in Google Scholar
Guarner F, Malagelada J. Gut flora in health and disease. The Lancet 2003. 361(9356): 512–519.10.1016/S0140-6736(03)12489-0GuarnerFMalageladaJGut flora in health and diseaseThe Lancet20033619356512519Open DOISearch in Google Scholar
Heinlen L, Ballard JD. Clostridium difficile infection. The American Journal of the Medical Sciences 2010;340(3): 247–252.10.1097/MAJ.0b013e3181e939d820697257HeinlenLBallardJDClostridium difficile infectionThe American Journal of the Medical Sciences20103403247252293593620697257Open DOISearch in Google Scholar
Leffler DA, Lamont JT. Treatment of Clostridium difficile-associated disease. Gastroenterology 2009; 136(6):1899–1912.10.1053/j.gastro.2008.12.070LefflerDALamontJTTreatment o. Clostridium difficile-associated diseaseGastroenterology200913661899191219457418Open DOISearch in Google Scholar
Pepin J, Valiquette L, Alary ME, et al. Clostridium difficile-associated diarrhea in a region of Québec from 1991 to 2003: a changing pattern of disease severity. CMAJ 2004;171:466–472.10.1503/cmaj.1041104PepinJValiquetteLAlaryMEet alClostridium difficile-associated diarrhea in a region of Québec from 1991 to 2003: a changing pattern of disease severityCMAJ200417146647251464315337727Open DOISearch in Google Scholar
Benea S, Popescu GA, Badicut I, Florea D, Petrache D, Gavriliu L, et al. Clostridium difficile infections hospitalized in Romanian Institute of Infectious Diseases during the first three months of 2012. Poster Presentation, 4th International C. difficile Symposium, September 20-22, Bled, Slovenia.BeneaSPopescuGABadicutIFloreaDPetracheDGavriliuLet alClostridium difficile infections hospitalized in Romanian Institute of Infectious Diseases during the first three months of 2012. Poster Presentation, 4th InternationaC. difficileSymposium, September 20-22Bled, SloveniaSearch in Google Scholar
Janarthanan S, Ditah I, Adler DG, et al. Clostridium difficile-associated diarrhea and proton pump inhibitor therapy: a meta-analysis. The American Journal of Gastroenterology 2012;107:1001–1110.10.1038/ajg.2012.17922710578JanarthananSDitahIAdlerDGet alClostridium difficile-associated diarrhea and proton pump inhibitor therapy: a meta-analysisThe American Journal of Gastroenterology20121071001111022710578Open DOISearch in Google Scholar
Leonard J, Marshall JK, Moayyedi P. Systematic review of the risk of enteric infection in patients taking acid suppression. The American Journal of Gastroenterology 2007;102:2047–2056.10.1111/j.1572-0241.2007.01275.x17509031LeonardJMarshallJKMoayyediPSystematic review of the risk of enteric infection in patients taking acid suppressionThe American Journal of Gastroenterology20071022047205617509031Open DOISearch in Google Scholar
Imhann F, Bonder MJ, Vich Vila A, Fu J, Mujagic Z, Vork L, et al. Proton pump inhibitors affect the gut microbiome. Gut 2016;65(5):740–748. doi: 10.1136/gutjnl-2015-310376. Epub https://emedicine.medscape.com/article/186458-overview[Accessed 2nd March, 2019].10.1136/gutjnl-2015-31037626657899ImhannFBonderMJVich VilaAFuJMujagicZVorkLet alProton pump inhibitors affect the gut microbiomeGut201665574074810.1136/gutjnl-2015-310376https://emedicine.medscape.com/article/186458-overview2nd March, 2019485356926657899Open DOISearch in Google Scholar
McDonald LC, Coignard B, Dubberke E, Song X, Horan T, Kutty PK. Recommendations for surveillance of Clostridium difficile-associated disease. Infection Control & Hospital Epidemiology 2007; 28(2):140–145 (ISSN: 0899-823X).10.1086/511798McDonaldLCCoignardBDubberkeESongXHoranTKuttyPKRecommendations for surveillance of Clostridium difficile-associated diseaseInfection Control & Hospital Epidemiology2007282140145ISSN: 0899-823X17265394Open DOISearch in Google Scholar
Popescu GA, Szekely E, Codita I, Talapan D, Serban R, Ruja G. Ghid de diagnostic, tratament si prevenire a infectiilor determinate de Clostridium difficile Bucharest 2016. Available from: http://mainicurateinspitale.ro/wp-content/uploads/2016/08/Ghid-diagnostic-tratament-si-prevenire-Clostridium-difficile.pdf[Accessed 2nd March, 2019].PopescuGASzekelyECoditaITalapanDSerbanRRujaGGhid de diagnostic, tratament si prevenire a infectiilor determinate dClostridium difficile Bucharest2016Available fromhttp://mainicurateinspitale.ro/wp-content/uploads/2016/08/Ghid-diagnostic-tratament-si-prevenire-Clostridium-difficile.pdfAccessed 2nd March, 2019Search in Google Scholar
Pepin J. Improving the treatment of Clostridium difficile-associated disease: where should we start? Clinical Infectious Diseases 2006, 43(5):553–555.10.1086/506357PepinJImproving the treatment o. Clostridium difficile-associated disease: where should we start?Clinical Infectious Diseases200643555355516886145Open DOISearch in Google Scholar
Musgrave CR, Bookstaver PB, Sutton SS, Miller AD. Use of alternative or adjuvant pharmacologic treatment strategies in the prevention and treatment of Clostridium difficile infection. The International Journal of Infectious Diseases 2011;15:e438–e448.10.1016/j.ijid.2011.03.017MusgraveCRBookstaverPBSuttonSSMillerADUse of alternative or adjuvant pharmacologic treatment strategies in the prevention and treatment o. Clostridium difficile infectionThe International Journal of Infectious Diseases201115e438e44821596604Open DOISearch in Google Scholar
Brown KA et al. Meta-analysis of antibiotics and the risk of community-associated Clostridium difficile infection. Antimicrobial Agents and Chemotherapy. 2013; 57:2326. Available from: http://dx.doi.org/10.1128/AAC.02176-1210.1128/AAC.02176-1223478961BrownKAet alMeta-analysis of antibiotics and the risk of community-associated Clostridium difficile infectionAntimicrobial Agents and Chemotherapy2013572326Available fromhttp://dx.doi.org/10.1128/AAC.02176-12363290023478961Open DOISearch in Google Scholar
Deshpande A et al. Community-associated Clostridium difficile infection and antibiotics: a meta-analysis. Journal of Antimicrobial Chemotherapy 2013 Apr 25; [e-pub ahead of print]. Available from: http://dx.doi.org/10.1093/jac/dkt129DeshpandeAet alCommunity-associated Clostridium difficile infection and antibiotics: a meta-analysisJournal of Antimicrobial Chemotherapy2013Apr 25; [e-pub ahead of print]. Available fromhttp://dx.doi.org/10.1093/jac/dkt12910.1093/jac/dkt12923620467Search in Google Scholar
Obuch-Woszczatyński P, Dubiel G, Harmanus C, Kuijper E, Duda U, Wultańska D, van Belkum A, Pituch H. Emergence of Clostridium difficile infection in tuberculosis patients due to a highly rifampicin-resistant PCR ribotype 046 clone in Poland. European Journal of Clinical Microbiology & Infectious Diseases 2013; 32:1027–1030. Available from: doi: 10.1007/s10096-013-1845-5.10.1007/s10096-013-1845-5Obuch-WoszczatyńskiPDubielGHarmanusCKuijperEDudaUWultańskaDvan BelkumAPituchHEmergence of Clostridium difficile infection in tuberculosis patients due to a highly rifampicin-resistant PCR ribotype 046 clone in PolandEuropean Journal of Clinical Microbiology & Infectious Diseases20133210271030Available from: doi10.1007/s10096-013-1845-5370672223443474Open DOISearch in Google Scholar
Lee YM, Huh KC, Yoon SM, Jang BI, Shin JE, Koo HS, et al. Incidence and clinical outcomes of Clostridium difficile infection after treatment with tuberculosis medication. Gut and Liver 2016; 10(2): 250–254.10.5009/gnl14435LeeYMHuhKCYoonSMJangBIShinJEKooHSet alIncidence and clinical outcomes o. Clostridium difficile infection after treatment with tuberculosis medicationGut and Liver2016102250254478045526260753Open DOISearch in Google Scholar
Wipperman MF, Fitzgerald DW, Juste MAJ, Taur Y, Namasivayam S, Sher A, et al. Antibiotic treatment for tuberculosis induces a profound dysbiosis of the microbiome that persists long after therapy is completed. Scientific Reports 2017;7:10767. Published online 2017 Sep 7. doi: 10.1038/s41598-017-10346-6.10.1038/s41598-017-10346-628883399WippermanMFFitzgeraldDWJusteMAJTaurYNamasivayamSSherAet alAntibiotic treatment for tuberculosis induces a profound dysbiosis of the microbiome that persists long after therapy is completedScientific Reports2017710767Published online 2017 Sep 7. doi10.1038/s41598-017-10346-6558991828883399Open DOISearch in Google Scholar
Kullin BR, Reid S, Abratt V. Clostridium difficile in patients attending tuberculosis hospitals in Cape Town, South Africa, 2014–2015. African Journal of Laboratory Medicine 2018;7(2): a846. Available from: https://doi.org/10.4102/ajlm.v7i2.846KullinBRReidSAbrattVClostridium difficile in patients attending tuberculosis hospitals in Cape Town, South Africa, 2014–2015African Journal of Laboratory Medicine201872a846Available fromhttps://doi.org/10.4102/ajlm.v7i2.84610.4102/ajlm.v7i2.846629582830568907Search in Google Scholar
Legenza L, Barnett S, Rose W, Bianchini M, Safdar N, Coetzee R. Epidemiology and outcomes of Clostridium difficile infection among hospitalised patients: results of a multicentre retrospective study in South Africa. BMJ Global Health 2018;3:e000889. doi:10.1136/bmjgh-2018-000889.10.1136/bmjgh-2018-000889LegenzaLBarnettSRoseWBianchiniMSafdarNCoetzeeREpidemiology and outcomes o. Clostridium difficile infection among hospitalised patients: results of a multicentre retrospective study in South AfricaBMJ Global Health20183e00088910.1136/bmjgh-2018-000889605817130057799Open DOISearch in Google Scholar
Freedberg DE, Salmasian H, Cohen B, Abrams JA, Larson EL. Receipt of antibiotics in hospitalized patients and risk for Clostridium difficile infection in subsequent patients who occupy the same bed. JAMA Internal Medicine 2016, 176(12): 1801–1808. doi:10.1001/jamainternmed.2016.6193.10.1001/jamainternmed.2016.6193FreedbergDESalmasianHCohenBAbramsJALarsonELReceipt of antibiotics in hospitalized patients and risk fo. Clostridium difficile infection in subsequent patients who occupy the same bedJAMA Internal Medicine2016176121801180810.1001/jamainternmed.2016.6193513809527723860Open DOISearch in Google Scholar
